Search research articles
Contact Us
Filters
Showing results (531-540 of 633) with videos related to
Page
of 64
Sort By:
International Journal of Biological Sciences
|
April 20, 2026
Luteolin enhances antitumor immunity of B7-H3-targeted bispecific natural killer cell engagers against non-small cell lung cancer
Shuo Yang, Zhenfeng Zhang, Xi He, et al.
Molecular Cancer
|
February 15, 2022
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Li-Juan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Journal of Medicinal Chemistry
|
September 21, 2021
Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors
Shuo Yuan, Bo Wang, Qing-Qing Dai, et al.
Cancer Letters
|
April 18, 2026
New Insights into the Ambivalent Role and Clinical Implications of Tripartite Motif Family Proteins in Colorectal Cancer
Hailin Zou, Yaoyu Guo, Qingming Pan, et al.
Cancer Letters
|
January 24, 2025
An ER stress and mitochondrial apoptosis Co-inducer for enhanced cancer immunotherapy
Guangzhao Xu, Shuzhen Chen, Hekai Yang, et al.
Plos One
|
September 27, 2013
bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10)
Jun-Jiang Chen, Atish Patel, Kamlesh Sodani, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 12, 2025
Multifunctional Nano Immunostimulant: Overcoming Immunosuppressive Microenvironment for Antitumor Immunotherapy
Guanhong Guo, Wenda Zhong, Huishuang Zhao, et al.
International Journal of Biological Sciences
|
March 14, 2024
Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma
Bo Wang, Fang-Zheng Qi, Ping Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 17, 2024
ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C
Zi-Ning Lei, Najah Albadari, Qiu-Xu Teng, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
October 6, 2021
Cycloruthenated Self-Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers
Jia Li, Leli Zeng, Zheng Wang, et al.
Page
of 64
Search research articles
Search
Showing results (531-540 of 633) with videos related to
Sort By:
Page
of 64
International Journal of Biological Sciences
|
April 20, 2026
Luteolin enhances antitumor immunity of B7-H3-targeted bispecific natural killer cell engagers against non-small cell lung cancer
Shuo Yang, Zhenfeng Zhang, Xi He, et al.
Molecular Cancer
|
February 15, 2022
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Li-Juan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Journal of Medicinal Chemistry
|
September 21, 2021
Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors
Shuo Yuan, Bo Wang, Qing-Qing Dai, et al.
Cancer Letters
|
April 18, 2026
New Insights into the Ambivalent Role and Clinical Implications of Tripartite Motif Family Proteins in Colorectal Cancer
Hailin Zou, Yaoyu Guo, Qingming Pan, et al.
Cancer Letters
|
January 24, 2025
An ER stress and mitochondrial apoptosis Co-inducer for enhanced cancer immunotherapy
Guangzhao Xu, Shuzhen Chen, Hekai Yang, et al.
Plos One
|
September 27, 2013
bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10)
Jun-Jiang Chen, Atish Patel, Kamlesh Sodani, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 12, 2025
Multifunctional Nano Immunostimulant: Overcoming Immunosuppressive Microenvironment for Antitumor Immunotherapy
Guanhong Guo, Wenda Zhong, Huishuang Zhao, et al.
International Journal of Biological Sciences
|
March 14, 2024
Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma
Bo Wang, Fang-Zheng Qi, Ping Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
February 17, 2024
ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C
Zi-Ning Lei, Najah Albadari, Qiu-Xu Teng, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
October 6, 2021
Cycloruthenated Self-Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers
Jia Li, Leli Zeng, Zheng Wang, et al.
Page
of 64